Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial
Open accessPublished version of a preprint
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: As the increasing prevalence of type 2 diabetes mellitus has put pressure on health systems to appropriately manage these patients, there have been a growing number of mobile apps designed to improve the self-management of diabetes. One such app, BlueStar, has been shown to significantly reduce hemoglobin A1c (HbA1c) levels in small studies and is the first app in the United States to receive Food and Drug Administration approval as a mobile prescription therapy. However, the impact of the app across real-world population among different clinical sites and health systems remains unclear. Objective: The primary objective of this study was to conduct a pragmatic randomized controlled trial of the BlueStar mobile app to determine if app usage leads to improved HbA1c levels among diverse participants in real-life clinical contexts. We hypothesized that this mobile app would improve self-management and HbA1c levels compared with controls. Methods: The study consisted of a multicenter pragmatic randomized controlled trial. Overall, 110 participants randomized to the immediate treatment group (ITG) received the intervention for 6 months, and 113 participants randomized to the wait-list control (WLC) group received usual care for the first 3 months and then received the intervention for 3 months. The primary outcome was glucose control measured by HbA1c levels at 3 months. Secondary outcomes assessed intervention impact on patient self-management, experience of care, and self-reported health utilization using validated scales, including the Problem Areas in Diabetes, the Summary of Diabetes Self-Care Activities, and the EuroQol-5D. Intervention usage data were collected directly from the app. Results: The results of an analysis of covariance controlling for baseline HbA1c levels did not show evidence of intervention impact on HbA1c levels at 3 months (mean difference [ITG−WLC] −0.42, 95% CI −1.05 to 0.21; P=.19). Similarly, there was no intervention effect on secondary outcomes measuring diabetes self-efficacy, quality of life, and health care utilization behaviors. An exploratory analysis of 57 ITG participants investigating the impact of app usage on HbA1c levels showed that each additional day of app use corresponded with a 0.016-point decrease in participants’ 3-month HbA1c levels (95% CI −0.03 to −0.003). App usage varied significantly by site, as participants from 1 site logged in to the app a median of 36 days over 14 weeks (interquartile range [IQR] 10.5-124); those at another site used the app significantly less (median 9; IQR 6-51). Conclusions: The results showed no difference between intervention and control arms for the primary clinical outcome of glycemic control measured by HbA1c levels. Although there was low usage of the app among participants, results indicate contextual factors, particularly site, had a significant impact on overall usage. Future research into the patient and site-specific factors that increase app utilization are needed. Trial Registration: Clinicaltrials.gov NCT02813343; https://clinicaltrials.gov/ct2/show/NCT02813343 (Archived by WebCite at https://clinicaltrials.gov/ct2/show/NCT02813343)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With respect to glycemic control, telehealth appears noninferior (as good or superior) to traditional health care delivery for persons with T1D or T2D, particularly in those who require more interactions, are newly diagnosed, have higher A1C levels, are diagnosed with GDM, or have other comorbid conditions.1673–1681”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1676]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 2×
“Data were collected centrally by research assistants and inputted into the REDCap database.”
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 2×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
Global estimates of diabetes prevalence for 2013 and projections for 2035
Guariguata, L., Whiting, D. R., Hambleton, I., Beagley, J., Linnenkamp, U., & Shaw, J. E. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.002 · Cited by 4,642 · cited 1×
“The worldwide burden of type 2 diabetes mellitus (T2DM) continues to increase, with almost 9% of the global population expected to have T2DM by 2035 [1].”
Self-citationEffect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
The summary of diabetes self-care activities measure: results from 7 studies and a revised scale.
Toobert, D. J., Hampson, S. E., & Glasgow, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.943 · Cited by 2,561 · cited 2×
“Overall, there was no difference in patient-reported diabetes self-care behaviors (measured by PAID and Summary of Diabetes Self-Care Activities-6) or general health status (measured by EQ-5D) at 3 months between intervention arms in both the unadjusted and adjusted models (Multimedia Appendix 5).”
Eysenbach, G. (2005) · Journal of Medical Internet Research · doi:10.2196/jmir.7.1.e11 · Cited by 2,524 · cited 1×
“5% (77/223), while in line with prior electronic health (eHealth) studies, may have led to an underestimation of the clinical impact among participants [36,37].”
Self-Management Education for Adults With Type 2 Diabetes
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1159 · Cited by 1,750 · cited 1×
“Optimizing self-management of glycemic control and other risk factors in conjunction with pharmacologic therapy may be an efficient way to improve patient outcomes [2-5].”
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
Thorpe, K. E., Zwarenstein, M., Oxman, A. D., Treweek, S., Furberg, C. D., Altman, D. G., Tunis, S., Bergel, E., Harvey, I., Magid, D. J., et al. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2008.12.011 · Cited by 1,389
A Systematic Review of the Impact of Adherence on the Effectiveness of e-Therapies
Donkin, L., Christensen, H., Naismith, S. L., Neal, B., Hickie, I. B., & Glozier, N. (2011) · Journal of Medical Internet Research · doi:10.2196/jmir.1772 · Cited by 876 · cited 1×
“5% (77/223), while in line with prior electronic health (eHealth) studies, may have led to an underestimation of the clinical impact among participants [36,37].”
Whitehead, L., & Seaton, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4883 · Cited by 743 · cited 1×
“There are a growing number of mobile apps designed to improve the self-management of T2DM patients [10-12], although few have been rigorously evaluated.”
Research works printed but not linked: 1
- Gude, W, 2016, Stud Health Technol Inform, 228, 594
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Deniz-Garcia, A., Fabelo, H., Rodriguez-Almeida, A. J., Zamora-Zamorano, G., Castro-Fernandez, M., Alberiche Ruano, M. D. P., Solvoll, T., Granja, C., Schopf, T. R., Callico, G. M., et al. (2023) · Journal of Medical Internet Research · doi:10.2196/44030 · Cited by 268
Smartphone-Based Technology in Diabetes Management
Doupis, J., Festas, G., Tsilivigos, C., Efthymiou, V., & Kokkinos, A. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00768-3 · Cited by 133
Lee, Y., Kim, G., Jun, J. E., Park, H., Lee, W. J., Hwang, Y., & Kim, J. H. (2023) · Diabetes Care · doi:10.2337/dc22-1929 · Cited by 132
Artificial intelligence for diabetes care: current and future prospects
Sheng, B., Pushpanathan, K., Guan, Z., Lim, Q. H., Lim, Z. W., Yew, S. M. E., Goh, J. H. L., Bee, Y. M., Sabanayagam, C., Sevdalis, N., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00154-2 · Cited by 106
Self-citationSun, H., Zhang, K., Lan, W., Gu, Q., Jiang, G., Yang, X., Qin, W., & Han, D. (2023) · Journal of Medical Internet Research · doi:10.2196/51300 · Cited by 101
Eaton, C. K., Vallejo, N., McDonald, X., Wu, J., Rodríguez, R., Muthusamy, N., Mathioudakis, N. N., & Riekert, K. A. (2024) · Journal of Medical Internet Research · doi:10.2196/50508 · Cited by 139
Technology in the management of type 2 diabetes: Present status and future prospects
DALY, A. B., & Hovorka, R. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14418 · Cited by 107
He, Q., Zhao, X., Wang, Y., Xie, Q., & Cheng, L. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.14993 · Cited by 86
Digital therapeutics in the clinic
Phan, P., Mitragotri, S., & Zhao, Z. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10536 · Cited by 104
“BlueStar Rx) also involve tailored digital coaching and insights for optimizing the treatment plans.(64) Notably, these insulin dose titration/optimization applications are compatible with different insulin forms.”
BackgroundLee, E. Y., Cha, S.-A., Yun, J.-S., Lim, S.-Y., Lee, J.-H., Ahn, Y.-B., Yoon, K.-H., Hyun, M. K., & Ko, S.-H. (2022) · Journal of Medical Internet Research · doi:10.2196/37430 · Cited by 83
“%) in their first RCT with 30 patients [28,29].”
Stevens, S., Gallagher, S., Andrews, T., Ashall-Payne, L., Humphreys, L., & Leigh, S. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.936752 · Cited by 84
Mandracchia, F., Llauradó, E., Tarro, L., Valls, R. M., & Solà, R. (2020) · JMIR mhealth and uhealth · doi:10.2196/18339 · Cited by 85
“In addition, it is important to evaluate the apps’ efficacy in helping consumers self-manage food allergies or intolerances, since previous studies have demonstrated that commercial apps do not always provide the expected results when they are evaluated in trials [47-49].”
BackgroundAssessing the quality of mobile applications in chronic disease management: a scoping review
Agarwal, P., Gordon, D., Griffith, J., Kithulegoda, N., Witteman, H. O., Bhatia, R. S., Kushniruk, A. W., Borycki, E. M., Lamothe, L., Springall, E., et al. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00410-x · Cited by 89
Self-citationDevelopment and Validation of Digital Health Technology Literacy Assessment Questionnaire
Yoon, J., Lee, M., Ahn, J. S., Oh, D., Shin, S.-Y., Chang, Y. J., & Cho, J. (2022) · Journal of Medical Systems · doi:10.1007/s10916-022-01800-8 · Cited by 74
“In the trial, about half of the participants used the app for 10 days or less, and patients who were older, lacked individual motivation, and had low beliefs about the usefulness of digital health were significantly less likely to use mobile devices [3].”
BackgroundVarma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74
Spaulding, E. M., Marvel, F. A., Piasecki, R. J., Martin, S. S., & Allen, J. K. (2021) · JMIR Cardio · doi:10.2196/18834 · Cited by 84
“One of the studies that did not detect a significant difference between groups did not achieve the target sample size [32].”
BackgroundMethodInfluentialLee, C. S., Westland, H., Faulkner, K. M., Iovino, P., Thompson, J. H., Sexton, J., Farry, E., Jaarsma, T., & Riegel, B. J. (2022) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2022.104322 · Cited by 83
Distinguishing features in the assessment of mHealth apps
Tarricone, R., Petracca, F., Ciani, O., & Cucciniello, M. (2021) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1891883 · Cited by 62
“of contextual factors, such as site readiness and training activities, in determining app effectiveness [36].”
BackgroundCucciniello, M., Petracca, F., Ciani, O., & Tarricone, R. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00517-1 · Cited by 83
Guasti, L., Dilaveris, P., Mamas, M. A., Richter, D. J., Christodorescu, R., Lumens, J., Schuuring, M. J., Carugo, S., Afilalo, J., Ferrini, M., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14022 · Cited by 80
Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis
Colls, J., Lee, Y., Xu, C. Q., Corrigan, C., Lu, F., Marquez-Grap, G., Murray, M., Suh, D. H., & Solomon, D. H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa202 · Cited by 69
Behavior Change Effectiveness Using Nutrition Apps in People With Chronic Diseases: Scoping Review
Salas-Groves, E., Galyean, S., Alcorn, M., & Childress, A. (2022) · JMIR mhealth and uhealth · doi:10.2196/41235 · Cited by 70
Hangaard, S., Laursen, S. H., Andersen, J. D., Kronborg, T., Vestergaard, P., Hejlesen, O., & Udsen, F. W. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211064633 · Cited by 55
Robson, N., & Hosseinzadeh, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182212171 · Cited by 55
“Of the 29 studies included in the systematic review, 9 studies had evaluated one or more components of type 2 diabetes self-management behaviour as a secondary outcome measure [8,30,31,35,37,39,44,51,52].”
BackgroundZhang, A., Wang, J., Wan, X., Zhang, Z., Zhao, S., Guo, Z., & Wang, C. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074173 · Cited by 50
“Anderson (2010) [34] Y Y Y Y Y Rade Iljaž (2017) [46] Y Y Y Y RamachandranVinitha (2019) [43] Y Y Y Y Y Y Y Payal Agarwal (2019) [33] Y Y Y Y Y Y Gretchen A.”
BackgroundInfluentialVarma, N., Cygankiewicz, I., Turakhia, M. P., Heidbüchel, H., Hu, Y., Chen, L. Y., Couderc, J., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12795 · Cited by 54
Designing personalised mHealth solutions: An overview
Rivera-Romero, O., Gabarrón, E., Ropero, J., & Denecke, K. (2023) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2023.104500 · Cited by 58
Seid, A., Fufa, D. D., & Bitew, Z. W. (2024) · Frontiers in Digital Health · doi:10.3389/fdgth.2024.1282570 · Cited by 54
Konnyu, K. J., Yogasingam, S., Lépine, J., Sullivan, K., Alabousi, M., Edwards, A. L., Hillmer, M. P., Karunananthan, S., Lavis, J. N., Linklater, S., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014513 · Cited by 69
Self-citationBiskupiak, Z., Ha, V. V., Rohaj, A., & Bulaj, G. W. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020403 · Cited by 52
“Digital therapies for the treatment of diabetes type 2 were pioneered with the development of DTx BlueStar ® [5,315,316], and showed efficacy in reducing HbA1c [317,318].”
MethodIdentifying features of a mobile-based application for self-care of people living with T2DM
Mehraeen, E., Noori, T., Nazeri, Z., Heydari, M., Mehranfar, A., Moghaddam, H. R., & Aghamohammadi, V. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108544 · Cited by 44
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbüchel, H., Hu, Y., Chen, L. Y., Couderc, J., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12461 · Cited by 39
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 83
Poonprapai, P., Lerkiatbundit, S., & Saengcharoen, W. (2022) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-022-01389-5 · Cited by 42
“Published articles have indicated that mobile apps are advantageous to assist self-management in diabetes [13, 14].”
BackgroundAlmutairi, N., Vlahu‐Gjorgievska, E., & Win, K. T. (2023) · Informatics for Health and Social Care · doi:10.1080/17538157.2023.2165083 · Cited by 43
Steenkamp, D., Eby, E. L., Gulati, N., & Liao, B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/1932296821997923 · Cited by 33
Kim, Y., Lee, H., & Seo, J. M. (2021) · Western Journal of Nursing Research · doi:10.1177/0193945921994912 · Cited by 40
“In a previous study that applied a diabetes self-management app (Agarwal et al., 2019), HbA1c was not reduced.”
BackgroundMethodMorris, T., Aspinal, F., Ledger, J., Li, K., & Gomes, M. (2022) · PharmacoEconomics - Open · doi:10.1007/s41669-022-00377-9 · Cited by 38
“Agarwal (2019) [25] Al Hayek (2021) [22] Arora (2014) [26] Fico (2020) [14] Fountoulakis (2015) [29] Gilmer (2019) [23] Gordon (2014) [15] Katz (2012) [27] Kempf (2017) [16] Li (2018) [24] Lorig (2016) [33] Lu (2020) [19] Luley (2011) [17] Maxwell (2016) [20] McGloin (2020) [30] Menon (2017) [21] Musacchio (2011) [31]…”
BackgroundVersluis, A., Boels, A. M., Huijden, M. C. G., Mijnsbergen, M. D., Rutten, G. E. H. M., & Vos, R. C. (2025) · Diabetic Medicine · doi:10.1111/dme.70002 · Cited by 51
Padró‐Arocas, A., Quifer‐Rada, P., Aguilar‐Camprubí, L., & Tudela, D. M. (2020) · Research in Nursing & Health · doi:10.1002/nur.22095 · Cited by 30
Evaluation of mobile applications for patients with diabetes mellitus: A scoping review
Lee, J. L., & Kim, Y. (2024) · Healthcare · doi:10.3390/healthcare12030368 · Cited by 29
Zhou, T. T., Wang, R., Gu, S. J., Xie, L., Zhao, Q. H., Xiao, M., & Chen, Y. L. (2022) · JMIR mhealth and uhealth · doi:10.2196/39819 · Cited by 38
“They especially work well for patients with chronic diseases, such as arterial hypertension [27], diabetes [28], and heart failure [29].”
Park, S. W., Kim, G., Hwang, Y., Lee, W. J., Park, H., & Kim, J. H. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01179-x · Cited by 36
Tarricone, R., Petracca, F., Svae, L., Cucciniello, M., & Ciani, O. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105091 · Cited by 26
“86 – 89 As for other factors adopted during the development process, 21 studies (36.8”
BackgroundInfluentialYoshida, Y., Patil, S. J., Brownson, R. C., Boren, S. A., Kim, M. J., Dobson, R., Waki, K., Greenwood, D. A., Torbjørnsen, A., Ramachandran, A., et al. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa041 · Cited by 26
Ruiz-León, A. M., Casas, R. M., Castro‐Barquero, S., Alfaro-González, S., Radeva, P. I., Sacanella, E., Casanovas-Garriga, F., Pérez-Gesalí, A., & Estruch, R. (2024) · Journal of Medical Internet Research · doi:10.2196/58319 · Cited by 43
“This may be attributed to limited app usage, consistent with findings by Agarwal et al [11], and the inherent challenges in altering dietary habits influenced by external (food industry) and internal (long-term preferences) factors [69].”
Agarwal, P., Kithulegoda, N., Bouck, Z., Bosiak, B., Birnbaum, I., Reddeman, L. E., Steiner, L., Altman, L., Mawson, R., Propp, R., et al. (2019) · Journal of Medical Internet Research · doi:10.2196/15424 · Cited by 24
“Exploring factors related to patient engagement and contextual factors impacting use in the clinic and patient context is also an important consideration that will be useful to evaluate in a larger trial [69].”
BackgroundSelf-citationMethodological Aspects in Randomized Clinical Trials of Nutritional Interventions
Martínez‐López, E., Pérez-Guerrero, E. E., Torres-Carrillo, N. M., López-Quintero, A., Betancourt‐Núñez, A., & Gutiérrez-Hurtado, I. A. (2022) · Nutrients · doi:10.3390/nu14122365 · Cited by 28
“The waiting list control is considered a control without treatment, so it will be very useful when studying conditions for which no established treatment or therapy exists; it will also be very useful when implementing a novel strategy that lacks a point of comparison, such as an investigation led by Payal Agarwal in…”
BackgroundFactors influencing self-care management in adult hemodialysis patients: An integrative review
Yasin, F. Y., Khraim, F., Santos, M., Forgrave, D., & Hamad, A. (2024) · Qatar medical journal · doi:10.5339/qmj.2024.12 · Cited by 29
“42 This disparity in the impact of smartphone applications may be due to the impractical design of the application or a lack of patient engagement and support when introducing smartphone applications.”
BackgroundZhang, X., Zhang, L., Lin, Y., Liu, Y., Yang, X., Cao, W., Ji, Y., & Chang, C. J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1068254 · Cited by 32
Effect of Mixed Variation of Magnesium Carbonate and Bottom Ash for Stabilization of Subgrade Soils
Firdaus, N. A. A., Ismanti, S., & Rifa'i, A. (2024) · The Open Civil Engineering Journal · doi:10.2174/0118749445304699240416074458 · Cited by 20
The Expanding Role of Digital Therapeutics in the Post-COVID-19 Era
Dang, A., Dang, D., & Rane, P. (2021) · The Open COVID Journal · doi:10.2174/2666958702101010032 · Cited by 20
Tanhapour, M., Peimani, M., Kalhori, S. R. N., Nasli‐Esfahani, E., Shakibian, H., Mohammadzadeh, N., & Qorbani, M. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02133-9 · Cited by 19
“This may result in underestimating of IDH effects [53, 105].”
BackgroundInfluentialZhang, Y., Liu, C., Luo, S., Huang, J., Li, X., & Zhou, Z. (2020) · JMIR mhealth and uhealth · doi:10.2196/17455 · Cited by 24
“A possible reason was the low use of the app among participants [40].”
A comparative study of deepfake facial manipulation technique using generative adversarial networks
Alkishri, W., Yousif, J. H., Bahri, M. A., Zakarya, M., Khan, N., Al-Maskari, S., & Gürhanlı, A. (2025) · Discover Artificial Intelligence · doi:10.1007/s44163-025-00337-2 · Cited by 27
Adu, M. D., Malabu, U. H., Malau‐Aduli, A. E. O., Drovandi, A. D., & Malau‐Aduli, B. S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17072573 · Cited by 20
“Preliminary efficacy results of these apps vary from none [50] to moderate [51,52] among participants in the intervention settings.”
BackgroundZhang, W., Yang, P., Wang, H., Pan, X., & Wang, Y. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01814-8 · Cited by 16
Patterson, K., Davey, R., Keegan, R. J., Niyonsenga, T., Mohanty, I., Bowen, S., Regan, E., Lander, M., van Berlo, S., & Freene, N. (2023) · JMIR mhealth and uhealth · doi:10.2196/48229 · Cited by 21
“…study, could result in an engagement level that is insufficient to achieve the intended effect [73], with increasing evidence that digital health XSL • FO RenderX apps for chronic disease self-management require ongoing patient engagement as a key determinant of overall clinical impact [74-77].”
BackgroundDropout rate in clinical trials of smartphone apps for diabetes management: A meta-analysis
Iqhrammullah, M., Refin, R. Y., Andika, F. F., Amirah, S., Abdurrahman, M. F., Alina, M., Yufika, A., & Abdullah, A. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111723 · Cited by 19
Sabben, G., Telfort, C., Morales, M., Zhang, W., Espinoza, J., Pasquel, F. J., & Winskell, K. (2024) · JMIR Diabetes · doi:10.2196/54223 · Cited by 18
“…to access to these apps may include platform (access to recent models of smartphones and data plans); affordability (paywalls or other restrictions); lack of integration with health care; and technology, data, and health literacy (excessive complexity or user burden and limited appeal) [19-21].”
BackgroundVarma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Cardiovascular Digital Health Journal · doi:10.1016/j.cvdhj.2020.11.004 · Cited by 19
“Efficacy for improving glycemic control in randomized controlled trials has shown mixed results (Agarwal 2019, Quinn 2011).”
ResultEmerging technologies for the management of type 2 diabetes mellitus
Shah, N. A., & Levy, C. J. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13188 · Cited by 18
Buck, H. G., Shadmi, E., Topaz, M., & SOCKOLOW, P. S. (2020) · Research in Nursing & Health · doi:10.1002/nur.22073 · Cited by 18
Carrera, A., Manetti, S., & Lettieri, E. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10702-z · Cited by 20
Dsouza, S. M., Venne, J., Shetty, S., & Brand, H. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01414-9 · Cited by 20
“Few of the systematic reviews and trials conducted have proven the effects of a scientific mHealth app, although the effectiveness of mHealth interventions varied widely among some of the studies [14, 15].”
BackgroundVarma, N., Cygankiewicz, I., Turakhia, M. P., Heidbüchel, H., Hu, Y., Chen, L. Y., Couderc, J., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab001 · Cited by 21
Li, M., Liu, S., Yu, B., Li, N., Lyu, A., Yang, H., He, H., Zhang, N., Ma, J., Sun, M., et al. (2025) · Journal of Medical Internet Research · doi:10.2196/63209 · Cited by 12
Huang, X., Zeng, J., Zhao, N., Fan, L., Ruan, D.-J., Wang, J., Hong, X., & Yu, C. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.900899 · Cited by 14
Gao, S., Kaudimba, K. K., Cai, J., Tong, Y., Tian, Q., Liu, P., Liu, T., Chen, P., & Wang, R. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.615861 · Cited by 13
Abdelmalak, N., Burns, J., Suhlrie, L., Laxy, M., & Stephan, A. (2024) · International Journal for Equity in Health · doi:10.1186/s12939-024-02267-4 · Cited by 14
“Seven studies reported on the income of their participants (see Table 6 in Additional file 11 for more details and descriptive analysis) [50, 56, 59, 69, 80, 83, 100].”
BackgroundGallagher, R. D., & Zhang, L. (2021) · European Journal of Cardiovascular Nursing · doi:10.1093/eurjcn/zvab053 · Cited by 14
“19 A potential explanation is that many participants (46.5”
BackgroundInfluentialComplementarity of Digital Health and Peer Support: “This Is What’s Coming”
Tang, P. Y., Duni, J., Peeples, M. M., Kowitt, S. D., Bhushan, N. L., Sokol, R. L., & Fisher, E. B. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.646963 · Cited by 11
“8% (240 of 463) in a pragmatic trial of the same DMA as used here that was also restricted to those with A1c levels at or above 8% and that included in-person identification by clinicians during regular clinic visits (40).”
BackgroundWu, Y., Keel, S., Carneiro, V. L. A., Zhang, S., Wang, W., Liu, C., Tang, X., Han, X., & He, M. (2024) · British Journal of Ophthalmology · doi:10.1136/bjo-2023-324913 · Cited by 17
“27 We believe that mobile device-based VA tests could still benefit from further improvement in this regard.”
BackgroundNguyen, M. E., Hossain, N., Tangri, R., Shah, J. B., Agarwal, P., Thompson-Hutchison, F., & Halperin, I. J. (2020) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2020.07.005 · Cited by 8
Self-citationImrisek, S. D., Lee, M., Goldner, D., Nagra, H., Lavaysse, L. M., Hoy‐Rosas, J., Dachis, J., & Sears, L. E. (2022) · JMIR Diabetes · doi:10.2196/34624 · Cited by 11
“While other studies of mHealth interventions have evaluated glucose outcomes at 3 months [37,38], insight into the sustained impact of forecasts on glucose beyond a 12-week period is limited.”
BackgroundSala-Cunill, A., Luengo, O., Curran, A., Moreno, N., Labrador‐Horrillo, M., Guilarte, M., Gonzalez‐Medina, M., Galvan‐Blasco, P., & Cardona, V. (2020) · Allergy · doi:10.1111/all.14626 · Cited by 12
The effectiveness of telemedicine in the management of type 2 diabetes: A systematic review
Dat, T. V., Binh, V., Hoang, T. M., Tu, V. L., Luyến, P. Đ., & Le, A. T.-K. (2024) · SAGE Open Medicine · doi:10.1177/20503121241271846 · Cited by 15
Smedslund, G., Østerås, N., & Hestevik, C. H. (2025) · JMIR mhealth and uhealth · doi:10.2196/68464 · Cited by 17
Vita, G., Magro, V. M., Sorbino, A., Ljoka, C., Manocchio, N., & Foti, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14207135 · Cited by 11
Chawla, R., Jaggi, S., Gupta, A. S., Bantwal, G., & Patil, S. H. (2022) · JMIR Diabetes · doi:10.2196/41401 · Cited by 14
“5% [15,19] or 8% [20] as one of the inclusion criteria.”
BackgroundZhang, Y., Guo, X., Zhang, N., Yan, X., Li, M., Zhou, M., He, H., Li, Y., Guo, W., Zhang, M., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18094854 · Cited by 10
“However, in the traditional types of lifestyle intervention programs, patients usually need to communicate with a clinician or qualified nutritionist in community health centers or physician’s offices, thus the traditional lifestyle intervention through in-person education programs is resource intensive [12].”
BackgroundInfluentialBarber-Gumbs, T., Lagerros, Y. T., Sena, L., Gittelsohn, J., Chang, L. W., Zachary, W. W., & Surkan, P. J. (2020) · JMIR Formative Research · doi:10.2196/18224 · Cited by 6
“While some diabetes apps link patients to health resources and providers [27,28], recent comparative reviews did not include addressing financial barriers to diabetes self-management as a comparison criterion [7-11,29].”
BackgroundSOCKOLOW, P. S., Buck, H. G., & Shadmi, E. (2021) · Health Informatics Journal · doi:10.1177/14604582211043914 · Cited by 10
Muñoz-Ramírez, S., Escribano-López, B., Rodrigo-Casares, V., Vergara-Hernández, C., Gil‐Mary, D., Sorribes‐Monrabal, I., Garcés‐Sánchez, M., Muñoz-Del-Barrio, M.-J., Albors-Fernández, A.-M., Úbeda-Sansano, M.-I., et al. (2021) · BMC Medical Research Methodology · doi:10.1186/s12874-021-01474-9 · Cited by 8
Mental Health Problems During COVID-19 and Attitudes Toward Digital Therapeutics
Kwon, M., Jung, Y., Lee, D., & Ahn, J. (2023) · Psychiatry Investigation · doi:10.30773/pi.2022.0150 · Cited by 7
Diabetes management intervention studies: lessons learned from two studies
Petersen, B., Vesper, I., Pachwald, B., DAGENBACH, N., Buck, S., Waldenmaier, D., & Heinemann, L. (2021) · Trials · doi:10.1186/s13063-020-05017-3 · Cited by 10
Liu, K., & Xia, Y. (2025) · Digital Health · doi:10.1177/20552076251326126 · Cited by 8
“Agarwal et al. 14 designed an m-health app-assisted intervention to support the self-monitoring of health behaviors and outcomes and deliver tailored, real-time feedback messages to facilitate patient behavior and motivation.”
Digital therapeutics as an emerging new therapy for diabetes mellitus: potentials and concerns
Li, S., Tao, J., Tang, J., Chu, Y., & Wu, H. (2024) · Endocrine Connections · doi:10.1530/ec-24-0219 · Cited by 11
“Some studies have revealed that even FDA-certified programs like BlueStar might show poor or no effectiveness due to factors such as low utilization rate, insufficient persistence time, and decreased patience of users https://doi.org/10.1530/EC-24-0219 S Li et al. during clinical trials ( 66).”
BackgroundInfluentialLi, M. Y., Chen, Y., Chen, X., Yao, H., & You, L. (2025) · Journal of Medical Internet Research · doi:10.2196/70428 · Cited by 14
“%) in Canada [29], 1 (5”
InfluentialSuresh, S., Bhardwaj, S., Rodrigues, H. C., Charly, D., Shekha, T. A. M., Jessy, A., Anirudhan, A., Abhishek, M. L., & Issac, T. G. (2025) · Journal of Medical Systems · doi:10.1007/s10916-025-02236-6 · Cited by 9
“Mobile applications like BlueStar, for example, have demonstrated benefits in self-management and glycaemic control in the treatment of diabetes [84].”
Grayek, E., Krishnamurti, T., Hu, L., Babich, O., Warren, K., & Fischhoff, B. (2023) · JMIR mhealth and uhealth · doi:10.2196/46237 · Cited by 6
“[30,33,34,36] 4 (17) None [27-29,31,32,35,37-50] b RCT: randomized controlled trial.”
BackgroundPopular Diabetes Mobile Applications for Medication Intake Monitoring
Babaskin, D., Litvinova, T. M., Babaskina, L. I., Krylova, O. V., & Winter, E. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00057 · Cited by 8
Dsouza, S. M., Shetty, S., Venne, J., Pundir, P., Rajkhowa, P., Lewis, M. G., & Brand, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060108 · Cited by 8
Lucha-López, M. O., Peracho, C. V., Hidalgo-García, C., Rodríguez‐Sanz, J., Tricás-Vidal, H. J., Hernández-Secorún, M., Monti-Ballano, S., Tricás-Moreno, J. M., & Lucha-López, A. C. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182211955 · Cited by 8
“HbA1c values in our sample were better than those registered in a previous study with a similar sample (9%) [41].”
ResultRubab, H., Aziz, F., Gul, R. B., & Froelicher, E. S. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-093798 · Cited by 8
Desveaux, L., Budhwani, S., Stamenova, V., Bhattacharyya, O. K., Shaw, J., & Bhatia, R. S. (2021) · Journal of Medical Internet Research · doi:10.2196/25797 · Cited by 7
“Usage of the mobile app varied considerably by site, suggesting that contextual factors play a central role in achieving impact [31].”
Self-citationLara, T. R., Muñoz-Torres, A. V., Salmerón, G. M., Vela, D., Bravo, P. M., Roy-García, I. A., & López, L. V. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.07.007 · Cited by 7
Paul, J., Jani, R., Davoren, P. M., & Knight-Agarwal, C. R. (2021) · JMIR Research Protocols · doi:10.2196/25085 · Cited by 7
The Role, Potential Benefits and Cost-effectiveness of Digital Tools for Diabetes Management
Carlson, A. L., Badlani, S., & Shah, V. N. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.05.002 · Cited by 8
Metadata
- Authors
- Agarwal, P., Mukerji, G., Desveaux, L., Ivers, N. M., Bhattacharyya, O., Hensel, J. M., Shaw, J., Bouck, Z., Jamieson, T., Onabajo, N., Cooper, M., Marani, H., Jeffs, L., & Bhatia, R. S.
- Affiliations
- University of Toronto (CA)
- Women's College Hospital (CA)
- St. Michael's Hospital (CA)
- Corresponding author
- Agarwal, Payal
- ORCID
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2019-01-10
- Volume
- 7
- Issue
- 1
- Pages
- e10321
- ISSN
- 2291-5222 (ISSN-L)
- PMC
- PMC6329896
- OpenAlex
- W2891497594
- Cited by
- 208
- References
- 41
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 39 · 2023: 32 · 2022: 32 · 2021: 35 · 2020: 18 · 2019: 5
- FWCI
- 22.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- JMIR mhealth and uhealth (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, mobile health apps, diabetes self-management, glycemic control, HbA1c, app usage, diabetes self-efficacy, quality of life, health care utilization, real-world evidence, patient experience, Problem Areas in Diabetes, Summary of Diabetes Self-Care Activities, EuroQol
- MeSH terms
- Self-Management, Adult, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Ontario, Surveys and Questionnaires, Blood Glucose Self-Monitoring, Mobile Applications, Pragmatic Clinical Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.